Oric Pharmaceuticals, Inc. — Director's Dealing 2020

Apr 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2020-04-23

Reporting Person: SCHELLER RICHARD H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-23	Stock Option (right to buy)	$16.00	A	33250	Acquired	2030-04-22	Common Stock (33250)	Direct

Footnotes

F1: One thirty-sixth (1/36) of the shares subject to the option shall vest May 23, 2020, and an additional thirty-sixth (1/36) of the shares subject to the option shall vest each month thereafter.